Zheng Quan Zhi Xing
Search documents
智洋创新: 2025年第三次临时股东大会会议资料
Zheng Quan Zhi Xing· 2025-09-05 16:13
Core Points - The company is holding its third extraordinary general meeting of shareholders in 2025 to ensure the rights of all shareholders and maintain order during the meeting [1][2][3] - The meeting will take place on September 15, 2025, at 15:00 in Zibo, Shandong Province, and will include both on-site and online voting [6][7] - A key agenda item is the proposal to abolish the supervisory board and amend the company's articles of association [7][8] Meeting Procedures - Attendees must verify their identity and sign in to confirm their attendance [1][2] - Shareholders and their representatives have the right to speak, inquire, and vote during the meeting [2][3] - The meeting will follow a structured agenda, including the announcement of attendance, discussion of proposals, and voting [6][7] Voting and Decision-Making - Voting will be conducted through a combination of on-site and online methods, with results announced after counting [3][6] - Shareholders must express their opinions on the proposals by indicating agreement, disagreement, or abstention [3][4] - The company will ensure that only authorized personnel can enter the meeting venue to maintain order [4][5] Legal and Compliance - A law firm will be present to witness the meeting and provide legal opinions [3][5] - The company emphasizes the importance of maintaining confidentiality and protecting shareholder rights during the meeting [3][4]
天宜新材: 关于2025年第二次临时股东大会增加临时提案的公告
Zheng Quan Zhi Xing· 2025-09-05 16:13
证券代码:688033 证券简称:天宜新材 公告编号:2025-043 北京天宜上佳高新材料股份有限公司 关于2025年第二次临时股东大会增加临时提案的 公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 股东大会有关情况 股份类别 股票代码 股票简称 股权登记日 A股 688033 天宜新材 2025/9/9 二、 增加临时提案的情况说明 公司已于2025 年 8 月 30 日公告了股东大会召开通知,直接持有22.27%股份 的股东吴佩芳女士,在2025 年 9 月 5 日提出临时提案并书面提交股东大会召集 人。股东大会召集人按照《上海证券交易所科创板上市公司自律监管指引第 1 号—规范运作》有关规定,现予以公告。 (1)《关于续聘 2025 年度审计机构的议案》 鉴于中审众环会计师事务所(特殊普通合伙)具备良好的职业操守和专业能 力,在对公司的审计工作中,能够做到勤勉尽责、认真履职,客观、公正地评价 公司财务状况和经营成果,公司拟续聘中审众环会计师事务所(特殊普通合伙) 为 2025 年度审计机构,聘期一年。公司 ...
泰坦科技: 上海泰坦科技股份有限公司2025年第一次临时股东大会决议公告
Zheng Quan Zhi Xing· 2025-09-05 16:13
《股东大会规则》等法律、法规、规范性文件以及《公司 章程》的相关规定,本次股东大会表决结果未包含本次股东大会会议《通知》中 未列入会议议程的议案,本次股东大会通过的决议合法、有效。 特此公告。 上海泰坦科技股份有限公司董事会 合《公司法》 《证券法》 | 证券代码:688133 证券简称:泰坦科技 公告编号:2025-036 | | | --- | --- | | 上海泰坦科技股份有限公司 | | | 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 | | | 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 | | | 重要内容提示: | | | ? | 本次会议是否有被否决议案:无 | | 一、 | 会议召开和出席情况 | | (一) | 股东大会召开的时间:2025 年 9 月 5 日 | | (二) | 89 股东大会召开的地点:上海市徐汇区石龙路 号 | | (三) | 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 | | 其持有表决权数量的情况: | | | 普通股股东人数 | 84 | | 51,900,777 | 普通股股东所持有表决权数量 ...
天目药业: 杭州天目山药业股份有限公司2025年第三次临时股东大会会议资料
Zheng Quan Zhi Xing· 2025-09-05 16:13
Core Points - The company is holding its third extraordinary general meeting of shareholders in 2025 on September 12, 2025, to discuss key governance changes [1][2] - The main proposals include the cancellation of the supervisory board, amendments to the articles of association, and the establishment of new governance systems [3][4][6] Proposal Summaries Proposal 1: Cancellation of the Supervisory Board and Amendment of Articles of Association - The company proposes to cancel the supervisory board, transferring its powers to the audit committee of the board of directors, and amend the articles of association accordingly [4][5] - Changes will include replacing terms related to the supervisory board with references to the audit committee to ensure compliance with the revised Company Law [4] Proposal 2: Cancellation of the Supervisory Board and Abolition of Supervisory Meeting Rules - The company aims to abolish the supervisory meeting rules in conjunction with the cancellation of the supervisory board, with the audit committee assuming the relevant responsibilities [5] Proposal 3: Revision and Establishment of Company Governance Systems - The company plans to revise and establish certain governance systems to enhance operational standards and governance levels, in line with the latest legal and regulatory requirements [6]
中南文化: 2025年第二次临时股东大会决议公告
Zheng Quan Zhi Xing· 2025-09-05 16:13
Group 1 - The company held a shareholder meeting on September 5, 2025, with a total of 705,956,465 shares represented, accounting for 29.7044% of the total voting shares [1] - The meeting adopted a combination of on-site and online voting methods to review several proposals [2] - The proposals received overwhelming support, with votes in favor reaching over 99% for multiple resolutions, indicating strong shareholder approval [3][4][5][6][7] Group 2 - The legal opinions provided by Beijing Zhide Law Firm confirmed that the meeting's procedures complied with relevant laws and regulations, ensuring the validity of the voting results [8]
中南文化: 北京植德律师事务所关于中南红文化集团股份有限公司2025年第二次临时股东大会的法律意见书
Zheng Quan Zhi Xing· 2025-09-05 16:13
Core Viewpoint - The legal opinion letter from Beijing Zhide Law Firm confirms the legality of the procedures, qualifications, and voting results of the second extraordinary general meeting of shareholders of Zhongnan Hong Culture Group Co., Ltd. held on September 5, 2025 [1][2][3][4][6]. Group 1: Meeting Procedures - The meeting was convened in accordance with the relevant laws, regulations, and the company's articles of association, with proper notification regarding the time, place, and voting methods [3][4]. - The legal opinion states that the convening and holding procedures of the shareholders' meeting comply with the requirements of the Company Law and other relevant regulations [4][6]. Group 2: Qualifications of Participants - A total of 268 shareholders attended the meeting, representing 705,956,465 shares, which accounts for 29.7044% of the total shares of Zhongnan Culture [4]. - The convenor of the meeting was the board of directors of Zhongnan Culture, and the qualifications of the convenor and attendees were verified as legitimate and valid [3][4]. Group 3: Voting Procedures and Results - The meeting passed several resolutions, including a special resolution to change the company's registered capital and amend the articles of association, with 99.8441% of the votes in favor [5][6]. - Other governance-related proposals were also approved with similar high approval rates, indicating strong shareholder support [5][6]. - The voting results were deemed legal and valid, confirming compliance with relevant laws and the company's articles of association [6].
博瑞医药: 关于参加2025年半年度科创板创新药行业集体业绩说明会的公告
Zheng Quan Zhi Xing· 2025-09-05 16:13
Group 1 - The company will hold a collective performance briefing for the innovative drug industry on September 16, 2025, from 15:00 to 17:00 [1][2] - The meeting will take place at the Shanghai Stock Exchange Roadshow Center, and it will be conducted in an online text interaction format [1][2] - Investors can submit questions from September 9, 2025, to September 15, 2025, before 16:00, through the Roadshow Center website or via the company's email [2][3] Group 2 - Key participants in the meeting will include the Chairman and General Manager Yuan Jiandong, Financial Director Zou Yuanlai, Independent Director Xu Dongdong, and Board Secretary Ding Nan [2] - After the briefing, investors can view the meeting's proceedings and main content on the Shanghai Stock Exchange Roadshow Center [3]
益生股份: 关于控股股东部分股份解除质押、质押及质押延期购回的公告
Zheng Quan Zhi Xing· 2025-09-05 16:13
证券质押明细表。 特此公告。 山东益生种畜禽股份有限公司 董事会 | 股东 | 持股数量 | | 持股 | | | | | 已质押 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 股份数量 | 持股份 | 总股本 | | | 占已 | | | 名称 | (股) | | 比例 | | | | | 股份限 | | 未质押股份 | | 限 | | | | | | | | | | | | | | | | (股) | 比例 | 比例 | | | 质 | | | 押 | | 占未质押 | | | | | | | | | | 股份比例 | | | | | | | 售和冻 | 股份 | 售和冻结数量 | | | | | | | | | | 结数量 | | (股) | | | | | | | | | | | 比例 | | | | | | | | | | | (股) | | | | | 曹积生 18.73% | 451,599,044 | | 40.82% | 221,330,000 | 49.01% | 20 ...
嘉泽新能: 嘉泽新能源股份有限公司关于控股股东及其一致行动人所持部分股份质押的公告
Zheng Quan Zhi Xing· 2025-09-05 16:13
Core Viewpoint - The announcement details the pledge of shares by the controlling shareholder and its concerted parties, indicating a significant portion of their holdings has been pledged as collateral for financing purposes, but it does not impact the company's operations or governance structure [1][4]. Group 1: Shareholding and Pledge Details - Beijing Jiashilongbo Investment Management Co., Ltd. holds 393,209,043 shares, representing 16.15% of the total share capital of 2,434,364,570 shares as of August 29, 2025 [1]. - After the pledge, Jiashilongbo has pledged a total of 217,706,330 shares, which is 55.37% of its holdings and 8.94% of the company's total share capital [1]. - Jinyuan Rongtai Investment Management (Ningxia) Co., Ltd. holds 374,319,234 shares, accounting for 15.36% of the total share capital, and has pledged 186,000,000 shares, which is 49.69% of its holdings and 7.64% of the total share capital [2]. Group 2: Pledge Purpose and Impact - The pledged funds will be used for Jiashilongbo's subsidiary, Shanghai Borong Yihong Technology Co., Ltd., to subscribe for shares issued by the company to specific targets [3]. - The pledged shares are not used as collateral for major asset restructuring or performance compensation [3]. - The pledging of shares by Jiashilongbo and Jinyuan Rongtai will not affect the company's main business, financing costs, or operational stability [4].
金达威: 关于取得发明专利证书的公告
Zheng Quan Zhi Xing· 2025-09-05 16:13
Core Viewpoint - Xiamen Jindawei Group Co., Ltd. has received a patent for a method and device for preparing 7-dehydrocholesterol and vitamin D3, which enhances the yield and purity of 7-dehydrocholesterol, contributing to the company's technological innovation and intellectual property protection [1][2]. Summary by Relevant Sections - **Patent Details** - Patent Name: A method and device for preparing 7-dehydrocholesterol and vitamin D3 [1] - Patent Number: ZL 2023 1 0125624.5 [1] - Application Date: February 16, 2023 [1] - Patent Holder: Xiamen Jindawei Vitamin Co., Ltd. [1] - Patent Term: Twenty years [1] - Certificate Number: 8222940 [1] - Authorization Announcement Date: September 5, 2025 [1] - **Technical Significance** - The invention belongs to the field of organic synthesis and aims to improve the yield and purity of 7-dehydrocholesterol [1]. - **Impact on Company** - The acquisition of the patent is not expected to have a significant impact on the company's production and operations but is beneficial for technological innovation and enhancing core competitiveness through intellectual property [1].